Design, Synthesis, and Biological Evaluation of Novel Deguelin-Based Heat Shock Protein 90 (HSP90) Inhibitors Targeting Proliferation and Angiogenesis
详细信息 查看全文
- 作者：Dong-Jo Chang ; Hongchan An ; Kyoung-suk Kim ; Hyun Ho Kim ; Jinkyung Jung ; Jung Min Lee ; Nam-Jung Kim ; Young Taek Han ; Hwayoung Yun ; Sujin Lee ; Geumwoo Lee ; Seungbeom Lee ; Ju Sung Lee ; Jong-Ho Cha ; Ji-Hyeon Park ; Ji Won Park ; Su-Chan Lee ; Sang Geon Kim ; Jeong Hun Kim ; Ho-Young Lee ; Kyu-Won Kim ; Young-Ger Suh
- 刊名：Journal of Medicinal Chemistry
- 出版年：2012
- 出版时间：December 27, 2012
- 年：2012
- 卷：55
- 期：24
- 页码：10863-10884
- 全文大小：892K
- 年卷期：v.55,no.24(December 27, 2012)
- ISSN：1520-4804
文摘
Deguelin exhibits potent apoptotic and antiangiogenic activities in a variety of transformed cells and cancer cells. Deguelin also exhibits potent tumor suppressive effects in xenograft tumor models for many human cancers. Our initial studies confirmed that deguelin disrupts ATP binding to HSP90 and consequently induces destabilization of its client proteins such as HIF-1伪. Interestingly, a fluorescence probe assay revealed that deguelin and its analogues do not compete with ATP binding to the N-terminus of HSP90, unlike most HSP90 inhibitors. To determine the key parts of deguelin that contribute to its potent HSP90 inhibition, as well as its antiproliferative and antiangiogenic activities, we have established a structure鈥揳ctivity relationship (SAR) of deguelin. In the course of these studies, we identified a series of novel and potent HSP90 inhibitors. In particular, analogues 54 and 69, the B- and C-ring-truncated compounds, exhibited excellent antiproliferative activities with IC50 of 140 and 490 nM in the H1299 cell line, respectively, and antiangiogenic activities in zebrafish embryos in a dose dependent manner (0.25鈥?.25 渭M).